Friday, December 08, 2023 1:46:40 AM
MARKETS QUOTE TRADES CHARTS NEWS OPTIONS COMPANY SHARE INFO KEY RATIOS FINANCIALS INSIDERS FILINGS ANALYST EARNINGS HISTORICAL
Niobay Metals Inc (NBYCF)
$0.04560.00(7.04%)
December 7, 2023 9:30 AMESTVolume: 100
USDOTCQB - U.S. REGISTEREDDELAYED PRICEMARKET CLOSED
Insider Summary
Last 3 Months
Volume
0 Buys0 Sells
Last 6 Months
Volume
8 Buys0 Sells
Last 12 Months
Volume
36 Buys0 Sells
Insiders
Name:
All
Transaction:
All
Select Year:
2023
Date Name Shares Traded Transaction Value Shares Held
2023-03-27 David, Jean-Sébastien 15,000 Buy in the public market at $0.18 per share $2,700.00 1,482,152
2023-03-27 David, Jean-Sébastien 10,000 Buy in the public market at $0.19 per share $1,900.00 1,467,152
2023-03-27 David, Jean-Sébastien 25,000 Buy in the public market at $0.17 per share $4,250.00 1,457,152
2023-03-23 David, Jean-Sébastien 5,000 Buy in the public market at $0.17 per share $850.00 1,432,152
2023-03-23 David, Jean-Sébastien 20,000 Buy in the public market at $0.18 per share $3,500.00 1,427,152
2023-03-13 David, Jean-Sébastien 12,000 Buy in the public market at $0.21 per share $2,460.00 1,407,152
2023-03-10 David, Jean-Sébastien 7,000 Buy in the public market at $0.22 per share $1,505.00 1,395,152
2023-03-10 David, Jean-Sébastien 3,000 Buy in the public market at $0.21 per share $630.00 1,388,152
2023-03-03 David, Jean-Sébastien 21,000 Buy in the public market at $0.22 per share $4,620.00 1,385,152
2023-02-23 David, Jean-Sébastien 8,000 Buy in the public market at $0.21 per share $1,680.00 1,364,152
2023-02-23 David, Jean-Sébastien 15,000 Buy in the public market at $0.22 per share $3,300.00 1,356,152
2023-02-16 David, Jean-Sébastien 15,000 Buy in the public market at $0.21 per share $3,150.00 1,341,152
2023-02-15 David, Jean-Sébastien 25,000 Buy in the public market at $0.21 per share $5,125.00 1,326,152
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM